News & Events

November 3, 2016

FOR IMMEDIATE RELEASE

NanoSpeed Diagnostics: 2016 Alberta Export Award Finalist

EDMONTON, Alberta – (November 2, 2016) - NanoSpeed Diagnostics Inc. ("NanoSpeed" or "the Company") is pleased to announce that it was chosen to be a finalist in the category of Advanced Technology and Innovation by the Alberta Export Awards presented by Edmonton Economic Development Corporation and the Edmonton International Airport.

The Company's Test4D™ product is currently being sold through distributors globally based in Europe, China, India and the Philippines.

The Alberta Export Awards are the province's most prestigious awards, paying tribute to the success and innovative approaches of Alberta export companies. Extending across industries and including both rural and urban representation, the awards are a celebration of the contributions exporters have made to both the provincial and national economy.

Winners of each of the categories will be announced at the gala luncheon on December 8, 2016 at the Renaissance Hotel in Edmonton, Alberta. This event attracts top exporters in the Alberta community and provides an invaluable opportunity for networking. To register for the 2016 Alberta Export Awards gala luncheon please visit http://www.albertaexportawards.com/registration-information/

About NanoSpeed Diagnostics Inc.

NanoSpeed, incorporated in 2009, develops proprietary diagnostic/screening test kit platforms based on their Lateral Flow Immuno Assay and Lab-on-a-Chip technologies. NanoSpeed is located at the Advanced Technology Centre at the Edmonton Research Park in Edmonton, Alberta. These technological advancements provide patients with cost effective and reliable testing tools that will address the increasing needs of the healthcare industry, regulatory agencies and consumers. For more information please visit: www.nanospeed.ca

About Vitamin D deficiency and Test4D™

Vitamin D deficiency is a common problem in Canada, where 60% of adults have suboptimal levels of 25-OH vitamin D. Vitamin D deficiency has been associated with abnormalities in absorption of calcium, phosphorus, and bone metabolism; cardiovascular disease; diabetes; cancer; osteomalacia and osteoporosis in adults; and rickets in children. Deficient vitamin D levels are typically the result of an inadequate intake of vitamin D through sunlight, diet, or supplements, or due to malabsorptive disorders.

25-OH vitamin D levels are currently measured through laboratory testing. Over the past decade, there has been an incremental surge in the demand for vitamin D testing, resulting in increasing costs to government supported healthcare systems. An alternative to laboratory testing is Point-of-Care-Testing (POCT), medical testing that occurs outside of a clinical laboratory and near the patient. Potential advantages of POCT include reduction in errors and costs to the healthcare system, and the provision of quick clinical diagnoses.

To address the demands of vitamin D testing, NanoSpeed Diagnostics Inc. developed Test4D™, a POCT device for the qualitative detection of 25-OH Vitamin D in human blood obtained via fingertip puncture.

Test4D™ is available for commercial sale through certain distributors, or can be purchased for research purposes directly from NanoSpeed.

June 20, 2016

FOR IMMEDIATE RELEASE

NanoSpeed Diagnostics and Test4D™ achieves major sales milestone

EDMONTON, Alberta – NanoSpeed Diagnostics Inc. ("NanoSpeed" or  "the Company") is pleased to announce that Test4D™, the world's first point-of-care test for vitamin D sufficiency, has reached sales of one million (1,000,000) tests since the product launch in 2013.

"The achievement of this milestone is both a demonstration of the strong demand for on-the-spot point of care testing, as well as the increasing recognition of the importance that vitamin D plays in our everyday health", said Dr. Seema Gupta, President & CEO of NanoSpeed. "Sales continue to grow at a record pace year-over-year as distribution demands grow for a high quality and reliable test for vitamin D."

Test4D™ is currently being sold through distributors globally based in Europe, China, India and the Philippines.

This sales milestone achievement represents record-breaking news for NanoSpeed.  As the Company works to add new distributors and to develop new tests for commercialization with its partners, management continues to demonstrate a commitment to sustainable growth.

Dr. Seema Gupta continues, "As we celebrate this milestone, we have always believed it is important to thank our customers, distribution partners, employees, research and development collaborators and investors for their continued support.  Additionally, we would like to thank TEC Edmonton and its Health Accelerator Program as well as our dedicated Executive-in-Residence for ongoing strategic counsel of our business development activities as we continue to grow and strengthen our company and brand."

Test4D™ is not approved for commercial use in Canada or the United States and is limited by federal law to research or investigational use only.

January 18, 2016

NanoSpeed Diagnostics enters into Research Collaboration with Dynalife Dx

EDMONTON, Alberta - (January 18, 2016) - NanoSpeed Diagnostics Inc. ("NanoSpeed") is pleased to announce a new multi-year research collaboration with Dynalife Dx Inc. ("Dynalife") to develop new point of care tests to help patients obtain faster information on their own health.

"We strongly believe that point of care diagnostics are the simplest and fastest way for patients to access critical information on their health", said Dr. Seema Gupta, President & CEO of Nanospeed. "We are very excited about our collaboration with Dynalife, given their deep expertise in laboratory diagnostics.  Their accreditations and commitment to quality means that we will be developing tests that meet the highest standards in Canada."

Under the research collaboration agreement, NanoSpeed and Dynalife will work together to accelerate the development of NanoSpeed's technologies which will provide critical new point of care tests to patients in Alberta.  NanoSpeed will further leverage their existing distribution network to export these tests globally.

"This partnership is another example of how we are supporting companies in our community to help diversify Alberta's economy while enhancing patient health," said Mr. Jason Pincock, CEO of Dynalife Dx Inc. "NanoSpeed's unique focus on near patient testing will create the opportunity for new clinical delivery models and we are very interested in exploring the application of NanoSpeed technology here in Alberta ."

About DynaLIFE Dx

DL is Alberta's largest privately owned Clinical Laboratory. DL is headquartered in Edmonton and employs over 1200 medical, technical, and support staff in Edmonton and throughout central and Northern Alberta. DL performs over 15 Million publicly funded laboratory tests annually for 1.5 Million Albertans in its state of the art laboratories. DL is recognized as one of Canada's Best Managed Companies and is recognized consistently as one of Alberta's Top 65 Employers. DL is accredited by the College of Physicians and Surgeons of Alberta and carries international accreditation through the College of American Pathologists. DL is a key training facility for laboratory training in Western Canada. For more information please visit: www.dynalifedx.com

 

Media Advisory

NanoSpeed Diagnostics Inc. to participate in the 2015 American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo

Edmonton, July 24, 2015 - NanoSpeed Diagnostics Inc. will participate in the 2015 AACC Annual Meeting and Clinical Lab Expo. The event takes place from July 26-July 30, 2015 at the Georgia World Congress Center in Atlanta, Georgia.

 

Media Advisory

NanoSpeed Diagnostics Inc. to participate in Arab Health 2016

Edmonton, January 18, 2016 - NanoSpeed Diagnostics Inc. will participate in Arab Health 2016. The Arab Health 2016 exhibition will showcase more than 4,000 companies exhibiting their latest innovations to more than 130,000 healthcare professionals attending from 163 countries. The event takes place from January 25-January 28, 2016, at the Dubai International Convention & Exhibition Centre in Dubai, UAE.

 

March 2 2015

NanoSpeed Announces Global Distribution Partnership with DiaSys Diagnostics Systems for Test4D™

Edmonton, Alberta - (March 2, 2015) - NanoSpeed Diagnostics, Inc. ("NanoSpeed") is pleased to announce an expansion of their exclusive distribution agreement with global diagnostics and instrumentation distributor, DiaSys Diagnostics Systems GmbH ("DiaSys"), to market their 25-OH Vitamin D deficiency test kit. Under the broadened agreement, DiaSys will market the point-of-care vitamin D test under their own brand, QDx™ worldwide except in those territories that are already part of NanoSpeed's network and certain other territories. DiaSys is a large point-of-care diagnostics technology company with locations in Europe, Asia and Latin America selling to over 100 countries.

"An important element of positioning our point-of-care vitamin D test to meet the needs of patients is having broad and diverse distribution," said Dr. Seema Gupta, President of NanoSpeed Diagnostics, Inc., a leading diagnostics company focused on providing portable, innovative and rapid testing solutions. "DiaSys has tremendous global reach and an unparalleled passion for safe and high-quality tests to bring the best result for patients. This agreement is an important milestone for our company and patient access to our vitamin D test. We would like to acknowledge the assistance of TEC Edmonton for business development.

Technical support and advisory services and financial support from the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP), along with the contributions from Western Economic Diversification and Alberta Innovates Technology Futures, were crucial to our company and its products.

NanoSpeed's vitamin D test is a patented and unique point-of-care test that provides information on Vitamin D deficiency within 10 minutes. This test requires only a single drop of blood from the patient and costs 90% less when compared to other standard or conventional tests.

Test4D® and QDx™ are not approved for commercial use in Canada or the United States and limited by federal law to research or investigational use only.

About DiaSys Diagnostics Systems GmbH

DiaSys Diagnostic Systems is a leading specialist in the development and manufacturing of diagnostic system solutions of highest quality, trusted by customers in more than 100 countries for over 20 years. Our product portfolio comprises more than 90 clinical chemistry and immunoturbidimetric reagents for routine and special diagnostics including suitable calibrators and controls. The DiaSys instrumentation product range covers automated clinical chemistry analyzers, semi-automated analyzers and POC instruments for near-patient testing.

DiaSys decided to focus further into POC: this strategic investment with global intent includes R&D, manufacturing and a portfolio of solutions, recently presented, under the QDx brand.

For more information, please visit www.diasys-diagnostics.com.

 

February 16, 2015

NanoSpeed Announces Distribution Partnership with Unilab for Test4D™

Edmonton, Alberta - (February 16, 2015) - NanoSpeed is pleased to announce that they have appointed an exclusive distributor in the Philippines for their 25-OH Vitamin D deficiency test kit - Test4D™. Unilab Laboratories, Inc. ("Unilab") is an independent manufacturer and distributor of healthcare products based in the Philippines.

"We are very pleased to grow begin growing our distributor network Asia, starting in the Philippines and with Unilab," said Dr. Seema Gupta, President of NanoSpeed Diagnostics, Inc., a leading diagnostics company focused on providing portable, innovative and rapid testing solutions. "Unilab has proven to themselves to be a strong presence as the largest pharmaceutical centre in the Phillipines. We are very pleased to welcome them to our global distribution network."

Test4D™ is a patented and unique point-of-care test that provides information on Vitamin D deficiency within 10 minutes. This test requires only a single drop of blood from the patient and costs 90% less when compared to other standard or conventional tests.

Test4D® is not approved for commercial use in Canada or the United States and is

limited by federal law to research or investigational use only. About Unilab Laboratories, Inc.

Unilab is the biggest pharmaceutical company in the Philippines, with a market share of some 20 percent which it has consistently maintained for more than three decades. Its portfolio includes some of the biggest prescription and consumer healthcare brands in the country.

For more information, please visit www.unilab.com.ph.

Success Story: Lab-free testing for thyroid disease.

More common than diabetes, thyroid disease affects millions of people of all ages. Balanced thyroid hormones levels are necessary for the development of a child's brain and skeleton. In adults, hyperthyroidism produces symptoms including anxiety, impatience, irritability and depression. Sometimes, it even leads to schizophrenia.

Read more on Alberta Innovates

 

July 24, 2014

NanoSpeed Announces Distribution Partnership with AKSA Medical for Test4D™

EDMONTON, Alberta - (BUSINESS WIRE) - NanoSpeed is pleased to announce that they have appointed an exclusive European distributor for their 25-OH Vitamin D deficiency test kit - Test4D™ following the announcement last week that Test4D™ is CE marked and registered for sale in the European Union. AKSA Medical is an independent distributor based in the Benelux specializing in the sale of in-vitro diagnostics and point of care testing.

"To accommodate rapidly growing interest in NanoSpeed's Test4D™ product in Europe, we have entered into this distributor agreement with AKSA Medical"

Tweet this

"To accommodate rapidly growing interest in NanoSpeed's Test4D™ product in Europe, we have entered into this distributor agreement with AKSA Medical," said Dr. Seema Gupta, President of NanoSpeed Diagnostics, Inc., a leading diagnostics company focused on providing portable, innovative and rapid testing solutions. "AKSA Medical is a leading clinical laboratory and diagnostics distributor dedicated to delivering value to their clients and to patients. We are pleased that AKSA Medical has chosen to distribute Test4D™ and we welcome them to our global distribution network."

Test4D™ is a patented and unique point-of-care test that provides information on Vitamin D deficiency within 10 minutes. This test requires only a single drop of blood from the patient and costs 90% less when compared to other standard or conventional tests.

Test4D™ is not approved for commercial use in Canada or the United States and is limited by federal law to research or investigational use only.

About AKSA Medical

AKSA Medical is an independent medical testing distributor based in the Benelux providing equipment and products ranging from routine laboratory assays to point-of-care testing. Since 2008, AKSA Medical has positioned itself to be a recognized and leading distributor of high quality testing products in Europe.

For more information, please visit www.aksamedical.com.

 

July 9, 2014

NanoSpeed Diagnostics receives CE mark approval for Test4D® Vitamin D test kit

Edmonton, Alberta – NanoSpeed Diagnostics announced today that it has CE marked the company's Test4D® vitamin D deficiency test kit, a point of care test to detect 25-OH vitamin D levels, for sales in Europe.  Standard vitamin D deficiency lab tests currently in use require weeks for test results, but Test4D™ is a new patented and unique point-of-care test that provides information on Vitamin D deficiency within 10 minutes. This test requires only a single drop of blood from the patient and costs 90% less when compared to other standard or conventional tests.

"The CE Mark for Test4D® is an important milestone," said Dr. Seema Gupta, President of NanoSpeed Diagnostics, Inc.  "This will allow NanoSpeed to provide this test to professional end-users and patients in the European Union who would like convenient and reliable information on vitamin D levels.  We are finalizing our plans for commercial launch in Europe in 2014."

Test4D® is not approved for commercial use in Canada or the United States and is limited by federal law to research or investigational use only.

October 2013

NanoSpeed has reached sales of over 200,000 units of its Test4D™ - Vitamin D deficiency test kit - since the launch of the product in April 2013.

November 2011

In the fall of 2011, NanoSpeed participated in two major events, the WAVE Conference in Lake Louise and The Health Symposium in Edmonton, to showcase its innovative Test4D™ POC test.

August 2011

NanoSpeed Diagnostics Inc. attracted angel investment.

January 2010

NanoSpeed Diagnostics Inc. attracted angel investment.

December 2009

NanoSpeed Diagnostics Inc. received the approval of grants from Provincial agencies.

August 2009

NanoSpeed Diagnostics Inc. received the approval of grants from Federal agencies

(IRAP). These funds along with other grants and investments will be used in product development to expand our product offerings in the market place.